Selective Wealth Management, Inc. Edwards Lifesciences Corp Transaction History

Selective Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$82.37 - $107.29 $22,239 - $28,968	-270 Reduced 27.27%	720 $59,000
Q2 2022 Jul 28, 2022	SELL	$86.5 - $128.27 $28,545 - $42,329	-330 Reduced 25.0%	990 $94,000
Q4 2021 Jan 18, 2022	BUY	$106.37 - $130.68 $35,102 - $43,124	330 Added 33.33%	1,320 $171,000
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $27,785 - $33,142	270 Added 37.5%	990 $112,000
Q2 2021 Aug 04, 2021	BUY	$83.84 - $104.76 $60,364 - $75,427	720 New	720 $74,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.